Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Iron overload and arthropathy].

Gérard Chalès1, Pascal Guggenbuhl, Yves Pawlotsky

  • 1Service de rhumatologie, hôpital Sud, 35203 Rennes Cedex 2. gerard.chales@chu-rennes.fr

La Revue Du Praticien
|April 10, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Brown tumors evolution.

Joint bone spine·2026
Same author

Investigating synovial trace elements as diagnostic markers in acute septic arthritis: an exploratory study.

Clinical rheumatology·2026
Same author

Prognostic Value of Combining Serum Tryptase and Bone Mineral Density in Predicting Fractures in Systemic Mastocytosis.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

More on bone microarchitecture and volumetric BMD in men and women with PLS3 gene variants assessed with HR-pQCT.

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2025
Same author

EULAR 2025 classification criteria for haemochromatosis arthropathy.

Annals of the rheumatic diseases·2025
Same author

[Microcrystalline arthropathies].

La Revue du praticien·2025
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Early diagnosis of genetic hemochromatosis is crucial. This iron overload disorder presents with joint pain and can be treated if detected early through symptoms like weakness and increased transferrin saturation.

Area of Science:

  • Rheumatology
  • Endocrinology
  • Genetics

Background:

  • Hemochromatosis is a condition of iron overload, which can be genetic or secondary.
  • Arthropathy is a key manifestation of hemochromatosis, mimicking degenerative joint disease and chondrocalcinosis.
  • Early diagnosis of genetic hemochromatosis is vital as it is common, treatable, and life-threatening.

Purpose of the Study:

  • To highlight the importance of early diagnosis for genetic hemochromatosis.
  • To describe the characteristic arthropathy associated with hemochromatosis.
  • To identify early clinical indicators of genetic hemochromatosis.

Main Methods:

  • Review of clinical manifestations of hemochromatosis.
  • Comparison of hemochromatosis-associated arthropathy with other joint diseases.

Related Experiment Videos

  • Identification of early biochemical and clinical markers.
  • Main Results:

    • Hemochromatosis arthropathy resembles degenerative joint disease and chondrocalcinosis, affecting unusual joints.
    • Early symptoms include weakness, arthralgias, and elevated serum transferrin saturation.
    • Genetic hemochromatosis is a frequent, treatable, yet potentially fatal condition if not diagnosed early.

    Conclusions:

    • Arthropathy is a significant and distinctive feature of hemochromatosis.
    • Recognizing early symptoms like arthralgias and increased transferrin saturation is key for timely diagnosis.
    • Prompt diagnosis and treatment of genetic hemochromatosis can prevent severe health consequences.